Weight and body fat changes in postpartum depot-medroxyprogesterone acetate users

Contraception

Volumn 88, Issue 1, 2013, Pages 169-176

  Nyirati, Christina M ^a   Habash, Diane L ^b   Shaffer, Lynn E T ^c  

^a OHIO UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OhioHealth   (United States)

Author keywords

BMI; Body composition; Body fat; Depot medroxyprogesterone acetate; Postpartum; Weight

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HORMONAL THERAPY; HUMAN; INSTRUMENT STERILIZATION; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MATERNAL OBESITY; PUERPERIUM; RISK ASSESSMENT; SALPINGECTOMY; WEIGHT CHANGE; WEIGHT GAIN;

ADIPOSITY; ADOLESCENT; ADULT; BODY COMPOSITION; BODY MASS INDEX; CONTRACEPTIVE AGENTS, FEMALE; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MEDROXYPROGESTERONE ACETATE; OBESITY; OHIO; OVERWEIGHT; POSTNATAL CARE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK; STERILIZATION, TUBAL; WEIGHT GAIN; YOUNG ADULT;

EID: 84879082751     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.10.016     Document Type: Article

References (66)

1. D.R. Mishel Pharmacokinetics of depot medroxyprogesterone acetate contraception J Reprod Med 41 1996 381 390
2. P. Schwallie, and J.R. Assenzo Contraceptive use - efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days Fertil Steril 24 1973 331 339
3. J.J. Kelsey Hormonal contraception and lactation J Hum Lact 12 1996 315 318
4. J.T. Queenan Contraception and breastfeeding Clin Obstet Gynecol 47 2004 734 739
5. S. Koetsawang The effects of contraceptive methods on the quality and quantity of breast milk Int J Gynaecol Obstet 25 Suppl. 1987 115 127
6. J. Jimenez, M. Ochoa, M.P. Soler, and P. Portales Long-term follow-up of children breast-fed by mothers receiving depot-medroxyprogesterone acetate Contraception 30 1984 523 533
7. L. Speroff, and D.R. Mishell Jr. The postpartum visit: it's time for a change in order to optimally initiate contraception Contraception 78 2008 90 98
8. World Health Organization A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects Contraception 34 1986 223 235
9. M. Mukherjea, P. Mukherjee, and R. Biswas Long-term contraception with Depo-Provera: a clinical evaluation Int J Fertil 25 1980 122 126
10. L.L. Moore, R. Valuck, C. McDougall, and W. Finks A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives Contraception 52 1995 215 220
11. R. Mainwaring, H.A. Hales, and K. Stevenson Metabolic parameter, bleeding, and weight changes in U.S. women using progestin-only contraceptives Contraception 51 1995 149 153
12. A.M. Kaunitz, P.D. Darney, D. Ross, K.D. Wolter, and L. Speroff Subcutaneous DMPA vs intramuscular DMPA: a 2 years study of contraceptive efficacy and bone mineral density Contraception 80 2009 7 17
13. S. Taneepanichskul, D. Reinprayoon, and U. Jaisamrarn Effects of DMPA on weight and blood pressure in long-term acceptors Contraception 59 1999 301 303
14. E. Espey, J. Steinhart, T. Ogburn, and C. Qualls Depo-Provera associated with weight gain in Navajo women Contraception 62 2000 55 58
15. L. Bahamondes, S. Del Castillo, G. Tabares, X.E. Arce, M. Perrotti, and C. Petta Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years Contraception 64 2001 223 225
16. M. Pantoja, T. Madeiros, M.C. Baccarin, S.S. Morais, L. Bahamondes, and A.M. Fernandes Variations in body mass index of users of depot medroxyprogesterone acetate as a contraceptive Contraception 81 2010 107 111
17. P. Segall-Gutierrez, D. Taylor, X. Liu, F.Z. Stanczyk, S. Azen, and D.R. Mishell Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously Contraception 81 2010 487 495
18. Z. Harel, F. Biro, L. Kollar, and J. Rauh Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant J Adolesc Health 19 1996 118 123
19. C. Paul, D. Skegg, and S. Williams Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation Contraception 56 1997 209 214
20. S. Haider, and P.D. Darney Injectable contraception Clin Obstet Gynecol 50 2007 898 906
21. S. Bakry, Z. Merhi, T. Scalise, M. Mahmoud, A. Fadiel, and F. Naftolin Depot-medroxyprogesterone acetate: an update Arch Gynecol Obstet 278 2008 1 12
22. S. Wanyonyi, W. Stones, and E. Sequeira Health-related quality of life changes among users of depot medroxyprogesterone acetate for contraception Contraception 84 2011 e17 e22
23. M.K. Clark, J.S. Dillon, M. Sowers, and S. Nichols Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception Int J Obes (Lond) 29 2005 1252 1258
24. Expert Panel Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert panel on the identification, evaluation, and treatment of overweight adults Am J Clin Nutr 68 1998 899 917
25. S.S. Anand, S. Islam, and A. Rosengren Risk factors for myocardial infarction in women and men: insights from the INTERHEART study Eur Heart J 29 2008 932 940
26. V.J. Carey, E.E. Walters, and G.A. Colditz Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study Am J Epidemiol 145 1997 614 619
27. L.J. Schouten, C. Rivera, and D.J. Hunter Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies Cancer Epidemiol Biomarkers Prev 17 2008 902 912
28. C. Rodriguez, E.E. Calle, D. Gakhrabadi-Shokoohi, E.J. Jacobs, and M.J. Thun Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women Cancer Epidemiol Biomarkers Prev 11 2002 822 828
29. H. Kuhl Breast cancer risk in the WHI study: the problem of obesity Maturitas 51 2005 83 97
30. A. Xiang, M. Kawakubo, S. Kjos, and T. Buchanan Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus Diabetes Care 29 2006 613 617
31. E. Gunderson, and B. Abrams Epidemiology of gestational weight gain and body weight changes after pregnancy Epidemiol Rev 22 2000 261 274
32. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 30 Suppl. 1 2007 S42 S47
33. L. Coppini, D. Waitzberg, and A. Campos Limitations and validation of bioelectrical impedance analysis in morbidly obese patients Curr Opin Clin Nutr Metab Care 8 2005 329 332
34. J. Jain, J. Jakimiuk, F. Bode, D. Ross, and A. Kaunitz Contraceptive efficacy and safety of DMPA-SC Contraception 70 2004 269 275
35. C.W. Callaway, W.C. Chumlea, and C. Bouchard Circumference T.G. Lohman, A.F. Roche, R. Martorell, Anthropometic standardization reference manual 1988 Human Kinetics Books Champaign, IL 39 54
36. C.C. Gordon, W.C. Chumlea, and A.F. Roche Stature, recumbent length, and weight T.G. Lohman, A.F. Roche, R. Martorell, Anthropometic standardization reference manual 1988 Human Kinetics Books Champaign, IL 3 8
37. G.G. Harrison, E.R. Buskirk, and J.E. Carter Skinfold thicknesses and measurement technique T.G. Lohman, A.F. Roche, R. Martorell, Anthropometric standardization reference manual 1988 Human Kinetics Books Champaign, IL 55 70
38. H.C. Lukaski, P.E. Johnson, W.W. Bolonpchu, and G.I. Lysken Assessment of fat-free mass using bioelectric impedance measurements of the human body Am J Clin Nutr 41 1985 810 817
39. E. Gunderson, B. Abrams, and S. Selvin Does the pattern of postpartum weight change differ according to pregravid body size? Int J Obes Relat Metab Disord 25 2001 853 862
40. L. Walker Low-income women's reproductive weight patterns: empirically based clusters of prepregnant, gestational, and postpartum weights Wom Health Iss 19 2009 398 405
41. G. Kac, M. Benício, G. Velásquez-Meléndez, J. Valente, and C.J. Struchiner Gestational weight gain and prepregnancy weight influence postpartum weight retention in a cohort of Brazilian women J Nutr 134 2004 661 666
42. N. Joseph, K. Hunkali, B. Wilson, E. Morgan, M. Cross, and K. Freund Pre-pregnancy body mass index among pregnant adolescents: gestational weight gain and long-term postpartum weight retention J Pediatr Adolesc Gynecol 21 2008 195 200
43. A. Bonny, J. Ziegler, R. Harvey, S. Debanne, M. Secic, and B. Cromer Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method Arch Pediatr Adolesc Med 160 2006 40 45
44. W.L. Risser, L.R. Gefter, M.S. Barratt, and J.M. Risser Weight change in adolescents who used hormonal contraception J Adolesc Health 24 1999 433 436
45. S. Mangan, P. Larsen, and S. Hudson Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate J Pediatr Adolesc Gynecol 15 2002 79 82
46. W.N. Spellacy, A.G. McLeod, W.C. Buhi, and S.A. Birk The effects of medroxyprogesterone acetate on carbohydrate metabolism: measurements of glucose, insulin, and growth hormone after twelve months' use Fertil Steril 23 1972 239 244
47. S. Tuttle, and V.E. Turkington Effects of medroxyprogesterone acetate on carbohydrate metabolism Obstet Gynecol 43 1974 685 692
48. A. Vermeulen, and M. Thiery Hormonal contraceptives and carbohydrate tolerance. II. Influence of medroxyprogesterone acetate and chronic oral contraceptives Diabetologia 10 1974 253 259
49. J.A. Perlman, R. Russell-Briefel, T. Ezzati, and G. Lieberknecht Oral glucose tolerance and the potency of contraceptive progestins J Chronic Dis 38 1985 857 860
50. K. Fahmy, M. Abdel-Razik, and M. Shaaraway Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile Contraception 44 1991 419 430
51. M.M. Hedderson, A. Ferrara, M.A. Williams, V.L. Holt, and N.S. Weiss Androgenicity of progestins in hormonal contraceptives and the risk of gestational diabetes mellitus Diabetes Care 30 2007 1062 1068
52. R.J. Sigal, M. El-Hashimy, B.C. Martin, J.S. Soeldner, A.S. Krolewski, and J.H. Warram Acute post-challenge hyperinsulinemia predicts weight gain Diabetes 46 1997 1025 1029
53. O.E. Odeleye, M. de Courten, D.J. Pettitt, and E. Ravussin Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children Diabetes 46 1997 1341 1345
54. E. Isganaitis, and R.H. Lustig Fast food, central nervous system insulin resistance, and obesity Arterioscler Thromb Vasc Biol 25 2005 2451 2462
55. S.E. Kahn, R.L. Hull, and K.M. Utzschneider Mechanisms linking obesity to insulin resistance and type 2 diabetes Nature 444 2006 840 846
56. M. Diamant Brain insulin signaling in the regulation of energy balance and peripheral metabolism Ideggyogy Sz 60 2007 97 108
57. M. Heliövaara, and A. Aromaa Parity and obesity J Epidemiol Community Health 35 1981 197 199
58. A. Mansour, and N. Ajeel Parity is associated with increased waist circumference and other anthropometric indices of obesity Eat Weight Disord 14 2009 e50 e55
59. E. Koch, M. Bogado, and F. Araya Impact of parity on anthropometric measures of obesity controlling by multiple confounders: a cross-sectional study in Chilean women J Epidemiol Community Health 62 2008 461 470
60. S.D. Hillis, P.A. Marchbanks, L.R. Tylor, and H.B. Peterson Poststerilization regret: findings from the United States Collaborative Review of Sterilization Obstet Gynelol 93 1999 889 895
61. L. Johansson, K. Solvoll, G.E. Bjorneboe, and C.A. Drevon Under- and overreporting of energy intake related to weight status and lifestyle in a nationwide sample Am J Clin Nutr 68 1998 266 274
62. G. Johansson, A. Wikman, A.M. Ahren, G. Hallmans, and I. Johansson Underreporting of energy intake in repeated 24-hour recalls related to gender, age, weight status, day of interview, educational level, reported food intake, smoking habits and area of living Public Health Nutr 4 2001 919 927
63. L.A. Braam, M.C. Ocke, H.B. Bueno-de-Mesquita, and J.C. Seidell Determinants of obesity-related underreporting of energy intake Am J Epidemiol 147 1998 1081 1086
64. B.L. Rooney, C.W. Schauberger, and M.A. Mathiason Impact of perinatal weight change on long-term obesity and obesity related illnesses Obstet Gynecol 106 2005 1349 1356
65. E. Gunderson, C.P. Quesenberry Jr., D.R. Jacobs Jr., J. Feng, C. Lewis, and S. Sidney Longitudinal study of prepregnancy cardiometabolic risk factors and subsequent risk of gestational diabetes mellitus: the CARDIA study Am J Epidemiol 172 2010 1131 1143
66. S. Sidney, D.B. Pettiti, G.A. Soff, D.L. Cundiff, K.K. Tolan, and C.P. Queensberry Jr. Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives Contraception 70 2004 3 10